EUVIMEDEUVIMED entdecken
Crossref

Cerebrospinal fluid neuromarker levels in patients with schizophrenia: a multiplex immunoassay study with a large sample

Shinsuke Hidese iD, Kotaro Hattori iD, Takako Enokida, Megumi Tatsumi, Ryo Matsumura, Hiroshi Kunugi iD

Psychiatry and Clinical Neurosciences · 2025

DOI: 10.1111/pcn.13848 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychiatry and Clinical Neurosciences, 2025. Verfasst von Shinsuke Hidese und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Teikyo University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Schizophrenia, Glial Fibrillary Acidic Protein, tau Proteins, Neurogranin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: SENSHIN Medical Research Foundation, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To test the hypothesis that neuromarker alternations associated with diagnosis, symptoms, or psychotropic medication use can be found in schizophrenia, we measured cerebrospinal fluid (CSF) neuromarkers in patients with schizophrenia and healthy controls.

Methods

This cross‐sectional study comprised 148 patients with schizophrenia (39.0 ± 11.0 years; 88 men and 60 women) and 220 healthy controls (44.6 ± 14.8 years; 135 men and 85 women), all of Japanese ethnicity. The Positive and Negative Syndrome Scale (PANSS) was used to assess symptom severity in patients with schizophrenia. The levels of eight of the 18 CSF neuromarker were successfully measured using a multiplex immunoassay. Trait and state markers were identified by patient and control groups comparison and symptom‐correlation analyses, respectively.

Results

CSF glial fibrillary acidic protein levels were significantly higher in patients with schizophrenia than in healthy controls. CSF neurogranin, total tau, and YKL‐40 levels were significantly lower in patients with schizophrenia than in healthy controls. Particularly, in patients with schizophrenia, CSF neurogranin, total tau, and YKL‐40 levels were lower in the psychotropic‐medicated group than in the psychotropic‐medication‐free group. CSF amyloid beta 1–42 levels were significantly and negatively correlated with PANSS negative scores. CSF macrophage migration inhibitory factor levels were significantly and positively correlated with PANSS positive, general psychopathology, and total scores. CSF neural cell adhesion molecule‐1 and S100 calcium‐binding protein B levels were significantly and positively correlated with PANSS positive scores.

Conclusion

Our findings suggest trait and state neuromarkers and antidementia‐like effects of psychotropics on the pathology of schizophrenia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaGlial Fibrillary Acidic Proteintau ProteinsNeurograninChitinase-3-Like Protein 1HumansMaleFemaleAdultMiddle AgedCross-Sectional StudiesBiomarkersImmunoassay

Stichwörter der Autor:innen

cerebrospinal fluid neuromarkerdiagnosispsychotropicsschizophreniasymptom

Substanzen

BiomarkersGlial Fibrillary Acidic Proteintau ProteinsNeurograninChitinase-3-Like Protein 1CHI3L1 protein, humanGFAP protein, humanMAPT protein, humanNRGN protein, human

Autor:innen und Institutionen

  • Department of Psychiatry, Teikyo University School of Medicine, Tokyo, Japan.
  • Department of Bioresources, Medical Genome Center, National Center of Neurology and Psychiatry, Tokyo, Japan.

ORCID-Profile: Shinsuke Hidese, Kotaro Hattori, Hiroshi Kunugi

Förderung

  • SENSHIN Medical Research Foundation
  • Japan Agency for Medical Research and Development

Zitieren

APA

Hidese, S., Hattori, K., Enokida, T., Tatsumi, M., Matsumura, R., & Kunugi, H. (2025). Cerebrospinal fluid neuromarker levels in patients with schizophrenia: a multiplex immunoassay study with a large sample. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/pcn.13848

Vancouver

Hidese S, Hattori K, Enokida T, Tatsumi M, Matsumura R, Kunugi H. Cerebrospinal fluid neuromarker levels in patients with schizophrenia: a multiplex immunoassay study with a large sample. Psychiatry and Clinical Neurosciences. 2025. doi:10.1111/pcn.13848

BibTeX
@article{Hidese2025,
  author = {Hidese, Shinsuke and Hattori, Kotaro and Enokida, Takako and Tatsumi, Megumi and Matsumura, Ryo and Kunugi, Hiroshi},
  title = {Cerebrospinal fluid neuromarker levels in patients with schizophrenia: a multiplex immunoassay study with a large sample},
  journal = {Psychiatry and Clinical Neurosciences},
  year = {2025},
  doi = {10.1111/pcn.13848}
}
Kostenlos starten →